SINCLAIR PHARMACEUTICALS LIMITED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ ODDZIAŁ W POLSCE
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
SINCLAIR PHARMACEUTICALS LIMITED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ ODDZIAŁ W POLSCE
Contacts
Registered address
Copy
Website
-
Not calculatedReliability
Prescore cannot be calculated due to significantly decreased turnover, expert evaluation needed.
Incorporation date
12/04/2021Share capital
No dataPrimary activity
Manufacture of pharmaceutical preparations (21.20.Z - PKD 2007)Representatives
1Representatives rights
KAŻDY Z DYREKTORÓW JEST UPOWAŻNIONY DO REPREZENTACJI SAMODZIELNEJRepresentatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
S***** H*** C**** | Member of the management board |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-302,481Net Profit (zł)
-302,481Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 6,981,815 |
| 378,132 |
| 317,095 |
| 0.20 |
| 1.76 |
| 4.54 |
| 1,206,330 |
| 1,873,536 |
| 0 |
| 0 |
| 2023 |
|---|
| 10,283,916 |
| 713,122 |
| 578,880 |
| 0.18 |
| 1.61 |
| 5.63 |
| 1,774,471 |
| 2,983,640 |
| 0 |
| 0 |
| 2024 |
|---|
| 4,511,454 |
| -225,254 |
| -302,481 |
| 0.68 |
| 1.85 |
| -6.70 |
| 2,558,120 |
| 3,607,490 |
| 0 |
| - |
| 2024 |
|---|
| 4,511,454 |
| -225,254 |
| -302,481 |
| 0.68 |
| 1.85 |
| -6.70 |
| 2,558,120 |
| 3,607,490 |
| 0 |
| - |
Turnover (zł)
2024
Turnover (zł)
4,511,454 zł
-56 % *
Profit before tax (zł)
-225,254 zł-132 % *
Net Profit (zł)
-302,481 zł-152 % *
Working capital requirement (%)
0.68 
277.78 % *
Liquidity ratio
1.85 
14.91 % *
Net profitability (%)
-6.70 %-219.01 % *
Equity (zł)
2,558,120 zł44 % *
Current liabilities (zł)
3,607,490 zł21 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
SINCLAIR PHARMACEUTICALS LIMITED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ ODDZIAŁ W POLSCE Documents
Date | Description |
|---|---|
23/10/2025 | OD 01.01.2024 DO 31.12.2024 |
27/08/2024 | OD 01.01.2023 DO 31.12.2023 |
13/08/2024 | OD 01.01.2022 DO 31.12.2022 |
09/08/2024 | OD 05.03.2021 DO 31.12.2021 |